AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program for Potential Treatment of Autoimmune Diseases and Other Immune-Mediated Disorde...
Original Article: Shire plc: AB Biosciences and Shire Enter Into Agreement for Development and Commercialization of AB Biosciences' PRIM Program
NEXT ARTICLE